Inhibikase Therapeutics, Inc. Other Non-Current Assets
Inhibikase Therapeutics, Inc. (IKT) had Other Non-Current Assets of $244.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $244.70K.
- 2026-03-31: Other Assets, Noncurrent $155.76K.
- 2025-12-31: Other Assets, Noncurrent $95.12K.
- 2025-09-30: Other Assets, Noncurrent $57.91K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $244.70K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $155.76K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $95.12K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $57.91K 10-Q · filed 2025-11-14 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |